Related Experiment Video
Updated: Jun 28, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
The evolving process of European combination product review, Part I
1Donawa Consulting, Rome, Italy. medonawa@donawa.com
Abstract:
A new European guideline on drug-eluting stents (DES) introduces for the first time detailed information that European drug authorities should review concerning the medicinal substance that is incorporated into this type of drug-device combination product. Part I of this article discusses European requirements that apply to DES. Part II will discuss the new guideline, other stent guidelines and evolving process of drug-device regulatory review in Europe.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Predicting Products: Substitution vs. Elimination
The following factors can influence the mechanisms competing against each other:
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Clinical Trials: Overview
Preclinical Development: Overview

